Our Company

We are dedicated to developing innovative solutions to enable the body to restore its natural connective tissue

Our History

The BEAR Implant was pioneered by Martha Murray, MD, founder of Miach Orthopaedics, at the Boston Children’s Hospital Department of Orthopaedic Surgery, with initial research funding provided by the NFL Players Association, Boston Children’s Hospital and the National Institutes of Health.

Our Products

Our initial focus is on the Bridge-Enhanced ACL Restoration (BEAR®) Implant, which represents a paradigm shift in the treatment of ACL tears from reconstruction to natural restoration.

The BEAR Implant

The BEAR Implant represents many firsts

First treatment with potential to change standard of care for ACL injuries

First innovative treatment for ACL tears in decades

First technology to clinically demonstrate restoration of the ACL

First De Novo approval in Sports Medicine and one of FDA’s most novel devices approved in 2020

Meet Our Senior Executive Team

Our leadership team has deep experience in the medical device industry and in bringing disruptive orthopedic advances to market.

Jamal Rushdy photo

Jamal Rushdy

President & Chief Executive Officer
Lisa Donnelly photo

Lisa Donnelly

Chief Marketing Officer
Christopher Joyce photo

Christopher Joyce

Chief Financial Officer
Rita Paparazzo photo

Rita Paparazzo, MBA

Chief Scientific & Regulatory Officer
Lou Ruggiero photo

Lou Ruggiero

Chief Sales Officer
Matthew Snodgrass photo

Matthew Snodgrass

Vice President of Quality Assurance & Regulatory Compliance
Stephen Wohlert photo

Stephen Wohlert, PhD

Vice President of Manufacturing

Meet Our Board of Directors

Matthew Curtin

NFL Players Inc.

Joyce Erony

Amzak Health

Arpesh Mehta

dsm-firmenich Ventures

Fernando Pacheco

Endeavour Vision

Tom Patton

SV Health Investors

Jamal Rushdy

Miach Orthopaedics

Andy Radford

Smith & Nephew

Michael Sjöström

Sectoral Asset Management